Brokerages forecast that Dextera Surgical Inc. (NASDAQ:DXTR) will report sales of $1.17 million for the current quarter, according to Zacks Investment Research. Two analysts have made estimates for Dextera Surgical’s earnings, with the highest sales estimate coming in at $1.18 million and the lowest estimate coming in at $1.16 million. Dextera Surgical reported sales of $720,000.00 during the same quarter last year, which indicates a positive year-over-year growth rate of 62.5%. The company is expected to announce its next earnings results on Tuesday, August 8th.

On average, analysts expect that Dextera Surgical will report full year sales of $1.17 million for the current fiscal year, with estimates ranging from $3.53 million to $3.55 million. For the next year, analysts expect that the business will post sales of $6.38 million per share, with estimates ranging from $5.10 million to $7.66 million. Zacks’ sales calculations are an average based on a survey of sell-side analysts that that provide coverage for Dextera Surgical.

Dextera Surgical (NASDAQ:DXTR) last issued its earnings results on Thursday, May 4th. The medical instruments supplier reported ($0.50) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.48) by $0.02. The business had revenue of $1.11 million for the quarter, compared to analysts’ expectations of $1.10 million.

Separately, Zacks Investment Research upgraded Dextera Surgical from a “sell” rating to a “hold” rating in a research note on Friday, June 30th.

Shares of Dextera Surgical (NASDAQ DXTR) traded down 13.63% during midday trading on Thursday, hitting $0.27. 6,869,604 shares of the stock were exchanged. The firm’s 50 day moving average price is $0.23 and its 200-day moving average price is $0.92. The stock’s market cap is $2.41 million. Dextera Surgical has a 52-week low of $0.17 and a 52-week high of $2.94.

TRADEMARK VIOLATION WARNING: “$1.17 Million in Sales Expected for Dextera Surgical Inc. (NASDAQ:DXTR) This Quarter” was reported by The Cerbat Gem and is owned by of The Cerbat Gem. If you are reading this article on another domain, it was stolen and reposted in violation of United States and international trademark & copyright laws. The correct version of this article can be read at https://www.thecerbatgem.com/2017/08/03/1-17-million-in-sales-expected-for-dextera-surgical-inc-nasdaqdxtr-this-quarter-updated-updated-updated.html.

Dextera Surgical Company Profile

Dextera Surgical Inc, formerly Cardica, Inc, designs and manufactures stapling devices that enable the advancement of minimally invasive surgical procedures. The Company is engaged in commercializing and developing its MicroCutter 5/80 stapler based on its staple-on-a-strip technology for use by thoracic, pediatric, bariatric, colorectal and general surgeons.

Get a free copy of the Zacks research report on Dextera Surgical (DXTR)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Stock Ratings for Dextera Surgical Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Dextera Surgical Inc. and related stocks with our FREE daily email newsletter.